Who is xclinical gmbh? About us XClinical GmbH, an innovative EDC-CDM system vendor headquartered in Munich (Germany) provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries. XClinical develops and markets Marvin.How can xclinical help? XClinical helps clinical study sponsors and CROs overcome these challenges and harness the power of their data to better manage clinical trials. Marvin, XClinical’s electronic all-in-one solution – provides a range of integrated modules in one platform, enabling the seamless flow of data to improve data quality.What is the new xclinical carenity merger? XClinical to merge with Carenity and Fortress Medical System forming a new data science company serving life science markets worldwide. Together, the three businesses will form a new, innovative data science company, powered by cutting edge technology.What can i do with eclinicalmobile? Users are able to access schedules, write prescriptions, and access encounters with the peace of mind that the data is encrypted and hosted on a secure gateway. eClinicalMobile provides user name and password as part of the log-on security function. Once logged in, icons are displayed for ease of use in choosing your function.
49 160 1545 Contact. Sabine Birkner Marketing Manager XClinical GmbH. Phone: +49 89 4522775-250 Mobile: + 49 160 1545711 E-mail: sabine.birkner@ xclinical.com. Organized by ...
XClinical GmbH Olga Steinle, +49 89 / 45 22 77 – 52 10 press@ xclinical.com Contacts XClinical GmbH Olga Steinle, +49 89 / 45 22 77 – 52 10 press@ xclinical.com
XClinical GmbH, an innovative EDC-CDM system vendor headquartered in Munich (Germany) provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries. XClinical develops and markets Marvin.
Anything that a patient might report can be considered a PRO, and this can be captured by paper, telephone, or via the web, tablet, and mobile technologies. PROs can be useful as primary and secondary endpoints, and for monitoring symptoms and adverse events. Using electronic data capture to collect ePROs is transforming clinical trials, by
Dopavision is pioneering the development of digital therapeutics in ophthalmology. We are developing a game-changing therapeutic for childhood myopia which can be easily administered by using a smartphone app. Our goal is to provide a clinically validated therapeutic to help in the fight against the global myopia crisis. About us.
XClinical GmbH Katharina Lang Phone: +49 (0)89 / 45 22 77 – 52 20 Email: press@ xclinical.com Contacts XClinical GmbH Katharina Lang Phone: +49 (0)89 / 45 22 77 – 52 20 Email: press@ xclinical.com
Contact Email [email protected] Phone Number 89 4522775000 XClinical is a provider of eClinical software solutions. They help clinical study sponsors and CROs harness the power of their data to better manage clinical trials.
Frequently Asked Questions regarding XClinical Where are XClinical’s headquarters? XClinical’s headquarters are in Arnulfstrasse 19, Munich, Bavaria, 80335, Germany What is XClinical’s phone number? XClinical’s phone number is +49 89 4522775000 What is XClinical’s official website? XClinical’s official website is //www.xclinical.com
Semmelweisstraße 3. 82152 Planegg. phone: +49 (0)89 6931489 00. fax: +49 (0)89 6931489 53. [email protected]. A next generation. gene therapy company. At ViGeneron, we are dedicated to developing innovative gene therapies. to treat ...
See how You too can Marvin Your Study! Meet Marvin, our all-in-one eClinical solution! Integrating EDC, WebPRO, IWRS, Reporting, Coding and much more. Fill out the form to experience Marvin with an XClinical expert! Get a free Demo. Contact us.
Acquisition of US-based Fortress Medical Systems accelerates BID Equity‘s life science software group around German XClinical and French Carenity ↓ 05/February/2021 Transactions BID Equity Fund II, a fund advised by BID Equity, acquires Fortress Medical Systems, the US-based vendor of Clindex®, an integrated CTMS and EDC system.
BID Equity Fund II, a fund advised by BID Equity, acquires a majority stake in XClinical GmbH. XClinical is a leading international provider of software solutions for drug and medical device studies. The XClinical platform fully implements the CDISC standard, which significantly accelerates the analysis and submission of data to regulatory authorities.
About us. XClinical is an international EDC vendor headquartered in Europe, founded in 2002. Our software solutions and technical services accelerate ...
We had no where to begin. Scouring the web at all hours of the night wasn't gonna cut it. RocketReach has given us a great place to start. Our workflow has solid direction now - we have a process in place the begins with RocketReach and ends with huge contact lists for our sales team..it probably saves Feedtrail about 3 months of work in terms of lead gathering.
22 775-140 +49 89 45 22 775-140 [email protected] David Renzelmann +49 89 45 22 775-135 [email protected] Lewis Baird +421 907 879 799 [email protected] Support Hotline: Technical support for our customers ...
XClinical GmbH Arnulfstr. 19 80335 Munich. Managing directors: Franciscus Pijpers, Manuel Neukum, Lars Kloppsteck Phone: +49 (0) 89 4522775 000 E-mail: info@ xclinical.com. You can reach XClinical’s data protection officer at: krupna LEGAL. Dr. Karsten Krupna Am Sandtorkai 77 20457 Hamburg. Phone: +49 (0) 40 31976927 E-mail: karsten-krupna
HAMBURG, Germany, March 15 th, 2021 – Data science group EvidentIQ with operations in Germany, France and the US, announced today the launch of their next generation eCOA and eFeasibility solutions for CROs and study sponsors.In a rapidly growing market, the EvidentIQ offering stands out as it combines a comprehensive tech stack with proven scientific ...
NEW YORK -- (BUSINESS WIRE)--Oct. 2, 2020-- IVERIC bio, Inc. (Nasdaq: ISEE) today reported that on October 1, 2020 , the Company granted a newly hired employee a non-statutory option to purchase 14,000 shares of the Company’s common stock. This grant was made pursuant to the Company’s 2019. Posted: October 02, 2020.